Short sellers impersonate MiMedx Executives to drive down stock price

MiMedx Group (MDXG) Warns Of Fake Emails to Impersonate Executives at Company (Street Insider)
MiMedx Group, Inc. (NASDAQ: MDXG), the leading biopharmaceutical company developing and marketing regenerative and therapeutic biologics utilizing human placental tissue allografts and patent-protected processes for multiple sectors of healthcare, warned today that certain individuals or entities not associated with the Company are establishing fake email accounts to impersonate executives at the Company.
The Company is aware of at least one instance in which emails were sent by someone using the C...